Electronic Clinical Outcome Assessment Solutions Global Market Report 2024

The electronic clinical outcome assessment solutions market size has grown rapidly in recent years. It will grow from $1.45 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth observed in the historical period can be attributed to regulatory support, a patient-centric approach, data quality and accuracy, cost efficiency, and time savings, along with the increasing number of global clinical trials.

The electronic clinical outcome assessment solutions market size is expected to see rapid growth in the next few years. It will grow to $2.84 billion in 2028 at a compound annual growth rate (CAGR) of 14.1%. The anticipated growth in the forecast period can be attributed to integration with wearable devices, decentralized and hybrid trials, patient engagement strategies, security and compliance measures, and remote monitoring and site collaboration. Major trends in the forecast period include artificial intelligence in clinical trials, clinical trial digitization, advancements in mobile technology, real-world evidence integration, and an emphasis on patient-reported outcomes (PROs).

The electronic clinical outcome assessment solutions market is anticipated to experience growth due to an upswing in research and development activities. Research and development activities encompass the initiatives undertaken by companies to innovate and introduce new products and services. Electronic clinical outcome assessment solutions contribute to these endeavors by electronically capturing outcomes data in clinical trials. As an illustration, in November 2023, the National Center for Science and Engineering Statistics, a US-based government agency, reported that in the fiscal year 2022, academic institutions allocated a total of $97.8 billion to research and development, indicating an increase of $8.0 billion compared to fiscal year 2021. Furthermore, internal funding for Research and Development (R&D) at universities exhibited a notable rise of $2.1 billion compared to the fiscal year 2021, while R&D funding from businesses to universities saw a growth of $587 million. Consequently, the surge in research and development activities is a key driver for the electronic clinical outcome assessment solutions market.

The anticipated growth of the electronic clinical outcome assessment solutions market is attributed to the rising number of clinical trials. Clinical trials are research studies or investigations conducted on human subjects to assess the safety, efficacy, and potential side effects of medical treatments, drugs, devices, or interventions. Electronic Clinical Outcome Assessment (eCOA) solutions play a vital role in clinical trials by offering a digital and streamlined approach to collecting patient-reported outcomes and other relevant data. For instance, as reported by the US-based digital media company Xtalks in May 2023, the global registration count on ClinicalTrials.gov reached 452,604 clinical trials in 2023, marking a significant increase from the reported over 365,000 registered trials in 2021. Furthermore, among these 452,604 clinical trials, 64,838 are actively recruiting participants. Hence, the escalating number of clinical trials serves as a catalyst for the growth of the electronic clinical outcome assessment solutions market.

A prominent trend in the electronic clinical outcome assessment solutions market is the increasing adoption of technological advancements. Key players in this market are actively engaged in developing innovative platforms to enhance their market standing. As an example, in January 2021, YPrime LLC, a US-based software company within the electronic clinical outcome assessment solutions market, introduced its 5th generation electronic clinical outcome assessment (eCOA) platform. This platform is designed to offer an enhanced user experience for patients, clinical investigators, sponsors, and Contract Research Organizations (CROs). The implementation of this cutting-edge technology is anticipated to bring improvements in clinical trial efficiency, site satisfaction, and patient compliance.

Key players in the electronic clinical outcome assessment solutions market are focusing their efforts on the development of innovative solutions, notably eCOA toolkits. An eCOA (Electronic Clinical Outcome Assessment) toolkit is a collection of software tools and resources strategically designed to facilitate the implementation and management of electronic methods for gathering patient-reported outcomes and other critical clinical trial data. As an illustration, in December 2022, Suvoda, a US-based software company, unveiled its electronic clinical outcome assessments (eCOA) design toolkit. This toolkit is seamlessly integrated with Suvoda IRT and eConsent, addressing previous shortcomings that have impacted the field of eCOA. It features a specialized language and authoring tool specifically crafted for the creation of eCOA questionnaires.

In November 2021, ERT, a US-based company specializing in eCOA solutions, joined forces with Bioclinica, another US-based company operating in clinical, imaging core lab, and clinical trial technology. This merger resulted in a company with enhanced scientific expertise and unparalleled global scale, establishing the most comprehensive endpoint technology platform. The objective is to accelerate the clinical trial process, streamline trial experiences, and enable the utilization of composite endpoints. Following the merger, the combined entity was rebranded as Clario.

Major companies operating in the electronic clinical outcome assessment solutions market report are International Business Machines Corporation, IQVIA Holdings Inc., DuPont de Nemours Inc., Oracle Corporation, Olin Corporation, ERT Clinical, Huntsman International LLC, Dassault Systemes SE, OmniComm Systems Inc., Hexion Inc., Parexel International Corporation, Veeva Systems Inc., TransPerfect Translations International Inc., KUKDO CHEMICAL CO. LTD., Medidata Solutions Inc., Signant Health, Clario Inc., ArisGlobal LLC, WIRB-Copernicus Group Inc., Merge Healthcare Inc., YPrime LLC, eClinical Solutions LLC, CRF Bracket Company, Anju Software Inc., Castor EDC B.V., Kayentis, Mednet Solutions LLC, Clinical Ink Inc., Cloudbyz Inc., Climedo Health GmbH, ClinCapture Inc.

North America was the largest region in the electronic clinical outcome assessment solutions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the electronic clinical outcome assessment solutions market during the forecast period. The regions covered in the electronic clinical outcome assessment solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic clinical outcome assessment solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of products within electronic clinical outcome assessment (eCOA) solutions include web-based eCOA solutions, on-premise-based eCOA solutions, and cloud-platform-based eCOA solutions. Web-based eCOA solutions denote programs distributed over a network, commonly a corporate intranet or the internet, and accessible through a standard web browser. These solutions encompass various approaches such as patient-reported outcome (PRO), clinician-reported outcome (ClinRO), observer-reported outcome (ObsRO), and performance outcome (PerfO). They find application in hospitals or healthcare providers, contract research organizations (CROs), pharmaceutical and biotechnology firms, medical device companies, and other end users.

The electronic clinical outcome assessment solutions market research report is one of a series of new reports that provides electronic clinical outcome assessment solutions market statistics, including electronic clinical outcome assessment solutions industry global market size, regional shares, competitors with an electronic clinical outcome assessment solutions market share, detailed electronic clinical outcome assessment solutions market segments, market trends and opportunities, and any further data you may need to thrive in the electronic clinical outcome assessment solutions industry. This electronic clinical outcome assessment solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic clinical outcome assessment solutions market consists of sales of eCOA live, eCOA multimedia, eCOA rescue studies, and suicidal ideation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.